Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 64.70p
   
  • Change Today:
      0.000p
  • 52 Week High: 64.80p
  • 52 Week Low: 32.85p
  • Currency: UK Pounds
  • Shares Issued: 551.02m
  • Volume: 24,690,272
  • Market Cap: £356.51m
  • RiskGrade: 119
  • Beta: 0.00
Select chart: 1 week | 1 month | 3 month | 6 month
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 201.38 43.59 4.98p 13.0 0.9 +15% n/a 0.0%
31-Dec-26 211.46 47.20 5.63p 11.5 0.9 +13% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
31-Dec-2025 201 n/a 201 201 202 n/a
31-Dec-2026 212 n/a 211 211 213 n/a
 
Earnings
31-Dec-2025 4.98p n/a 4.99p 4.99p 5.01p n/a
31-Dec-2026 5.63p n/a 5.59p 5.59p 5.67p n/a
 
Dividend
31-Dec-2025 n/a n/a n/a n/a n/a n/a
31-Dec-2026 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 2 2 2 2 4 0
Buy 0 0 0 0 0 0
Neutral 5 5 5 5 3 0
Sell 1 1 1 1 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 8 8 8 8 7 0
 
Average Rec 5.94 5.94 5.94 5.94 7.86 n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.70p
Change Today 0.000p
% Change 0.00 %
52 Week High 64.80p
52 Week Low 32.85p
Volume 24,690,272
Shares Issued 551.02m
Market Cap £356.51m
Beta 0.00
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
37.39% above the market average37.39% above the market average37.39% above the market average37.39% above the market average37.39% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
72.86% above the market average72.86% above the market average72.86% above the market average72.86% above the market average72.86% above the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Income Not Available
Growth
48.83% below the market average48.83% below the market average48.83% below the market average48.83% below the market average48.83% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 13-May-2025

Time Volume / Share Price
15:25 24,300,000 @ 64.64p
16:35 11,868 @ 64.70p
16:35 29 @ 64.70p
16:35 35 @ 64.70p
16:35 13 @ 64.70p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page